Moreover, metabolic and cognitive dysregulation in MDD patients had been evaluated and linked to the decreased concentrations of FGF19 and FGF21 through the PGC-1α/FNDC5 pathway. The gene discussed is PPARGC1A; the disease is major depressive disorder.